Q2i is a Digital Health Company
dedicated to developing, refining, validating, and commercializing innovative, evidence-based solutions.
Q2i’s technology is developed with the support of, and in conjunction with:
Q2i's academic partners include:
Q2i Research Projects
Project Title | Date started | Status | Academic Partner/s |
Buprenorphine induction low-dose to depot (build2depot): development of safe rapid transfer to depot medication and go/no go testing potential of remote community-based monitoring. | 2024 | In recruitment phase |  |
Prison release engagement trial, smartphone app to improve continuity of care post release for released prisoners (RPS) who want to stay drugfree | 2024 | In recruitment phase | |
PARCA (a digital tool) to improve justice and health | 2023 | Phase I STTR successfully completed, and now in Phase II (Dallas and Austin) |   |
Digital health technology improving successful community reintegration of recently released justice involved individuals with substance use disorders | 2020 | Phase I STTR successfully completed – results published |  |
Reward-Based technology to improve opioid use disorder treatment after an ED visit | 2019 | Phase I and Phase II STTR successfully completed Completed – in data analysis phase |   |
Technology improving the success of medication assisted treatment in primary care | 2019 | Phase I and Phase II STTR successfully completed – Manuscript drafted ready for peer review |  |
Project Title
Buprenorphine induction low-dose to depot (build2depot): development of safe rapid transfer to depot medication and go/no go testing potential of remote community-based monitoring.
Date started
2024
Status
In recruitment phase
Project Title
Prison release engagement trial, smartphone app to improve continuity of care post release for released prisoners (RPS) who want to stay drugfree
Date started
2024
Status
In recruitment phase
Project Title
PARCA (a digital tool) to improve justice and health
Date started
2023
Status
Phase I STTR successfully completed, and now in Phase II (Dallas and Austin)
Project Title
Digital health technology improving successful community reintegration of recently released justice involved individuals with substance use disorders
Date started
2020
Status
Phase I STTR successfully completed – results published
Project Title
Reward-Based technology to improve opioid use disorder treatment after an ED visit
Date started
2019
Status
Phase I and Phase II STTR successfully completed Completed – in data analysis phase
Project Title
Technology improving the success of medication assisted treatment in primary care
Date started
2019
Status
Phase I and Phase II STTR successfully completed – Manuscript drafted ready for peer review
Contact Us
"*" indicates required fields
